Scott Burkhart

Career chronology

• More than a decade before October 2021: Westpac and Commonwealth Bank of Australia — Corporate and institutional banking. Our People (Our People, Scott Burkhart biography, lines 10–15)

• Joined October 2021; COO until CEO appointment: Zeotech Limited — Chief Operating Officer. Executive Management Changes (p. 1, appointment release)

• 1 November 2023 to 9 September 2024: Zeotech Limited — Chief Executive Officer. Executive Management Changes (pp. 1–2, CEO change and employment terms)

• From 9 September 2024: Zeotech Limited — Chief Operating Officer. Annual Report 2025 (p. 25, service agreement amended to COO)

Education and qualifications

Education and professional qualification

As reported by cited source; accessed 2026-10-09 · issuer reported · low materiality

The issuer reports a Bachelor of Business (Management and Economics) from Auckland University of Technology. Credential not independently verified.

Attribution: Responsibility not applicable. Credential statements are issuer-reported; no university or professional-body verification was obtained.

Relevance: Relevant to role-fit assessment and subject to verification gap.

Executive Management Changes (p. 1, executive management changes)

Contributions and company outcomes

FY2026 project and commercial milestones

FY2026 through 2026-06-30; subsequent status through 2026-09-21 · issuer reported · medium materiality

During the cited period Zeotech reported the binding MSI DSO offtake, 2,300-tonne test-pit campaign, AusPozz concrete demonstration and methane-control field results, while Toondoon remained pre-commercial with approvals/logistics still progressing. These are company-level outcomes; the evidence does not isolate COO's personal contribution or establish booked DSO/AusPozz sales.

Attribution: Role overlaps event; causation unproven. Management responsibility overlapped the company period, but personal causal contribution is not documented.

Relevance: Relevant to delivery assessment; distinguish test/contract milestones from commercial production and realized cash revenue.

Annual Report to shareholders (FY2026 annual report, operating review and KMP disclosures); Quarterly Activities and Appendix 5B Cash Flow Report (pp. 1–8, activities report)

Business failures and setbacks

Pre-commercial status and funding dependence

FY2026 to 2026-06-30 · issuer reported · medium materiality

FY2026 reporting showed the Group remained pre-commercial, with a larger annual loss and operating cash outflow than the prior year; the annual report disclosed that additional funding may be needed to continue operations and develop assets. This is a company-level execution/funding risk during the executive's tenure, not evidence of personal misconduct or sole responsibility.

Attribution: Role overlaps event; causation unproven. The COO role overlapped the reported period; no personal causal attribution is established.

Relevance: Material to assessing delivery and capital allocation for a development-stage company.

Annual Report to shareholders (FY2026 annual report, financial statements and going-concern funding risk)

Litigation and enforcement

Abercorn project milestone-rights litigation settled

2023; acquisition term sheet dated 2019-08-09 · issuer reported · medium materiality

Zeotech reported that court-ordered mediation over milestone performance rights issued as consideration for the 2019 Abercorn acquisition concluded in 2023, with a binding settlement/release and discontinuance of both proceedings conditional on shareholder approval. The disclosure does not describe any finding of wrongdoing by the named executive; the dispute originated in a pre-appointment transaction and settlement terms were company-level.

Attribution: Role overlaps event; causation unproven. The MD/CEO roles overlapped settlement execution/oversight; no personal involvement or wrongdoing is documented.

Relevance: Relevant as company legal/governance context; resolution status disclosed as settlement, not adjudication of merits.

Quarterly Activities Report (March 2023 quarter) (p. 8, Settlement of legal proceedings)

Suitability for the current role

Role relevance and evidenced background

Background reviewed through 2026-10-09 · analyst inference · low materiality

The issuer biography supports relevant background for the assigned role. Current title in the selected roster: Chief Operating Officer. This supports role relevance at a high level; the public evidence reviewed does not establish personal causal responsibility for employer or project outcomes.

Attribution: Responsibility not applicable. Role-fit judgment based on the selected roster and issuer-reported professional background; no causal claim is made.

Relevance: Relevant to the current Chief Operating Officer responsibilities, subject to the evidence limitations recorded below.

Our People (Executive biography or corporate-directory entry for the named person)

Evidence gaps

• Prior-career date granularity and qualifications are mainly issuer-reported and not independently verified.

• Company milestones are not personally attributable from available evidence; the company remained pre-commercial at the cutoff.

• No exhaustive criminal, sanctions, court, regulator, safety, environment or qualification check was performed.